tiprankstipranks
FDA accepts Eisai/Biogen’s BLA for LEQEMBI in early AD treatment
PremiumThe FlyFDA accepts Eisai/Biogen’s BLA for LEQEMBI in early AD treatment
4d ago
J&J to acquire Intra-Cellular, Clearwater to buy Enfusion: Morning Buzz
Premium
The Fly
J&J to acquire Intra-Cellular, Clearwater to buy Enfusion: Morning Buzz
5d ago
Sage takeout bid implies zero enterprise value, says Mizuho
Premium
The Fly
Sage takeout bid implies zero enterprise value, says Mizuho
5d ago
Sage Therapeutics confirms $7.22 per share acquisition proposal from Biogen
PremiumThe FlySage Therapeutics confirms $7.22 per share acquisition proposal from Biogen
7d ago
SPY ETF News, 1/10/2025
Premium
Market News
SPY ETF News, 1/10/2025
8d ago
Biogen appoints Feire as Head of Business Development and External Innovation
Premium
The Fly
Biogen appoints Feire as Head of Business Development and External Innovation
9d ago
SPY ETF News, 1/7/2025
PremiumMarket NewsSPY ETF News, 1/7/2025
11d ago
VOO ETF News, 1/6/2025
Premium
Market News
VOO ETF News, 1/6/2025
12d ago
SPY ETF News, 1/3/2025
Premium
Market News
SPY ETF News, 1/3/2025
15d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100